Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qingdao Vland Biotech CoSHSE:603739 +1.18%81 Gross Margin % is 44.23% as of Mar. 2026, which is 7% below its 10-year median of 47.32. GuruFocus rates SHSE:603739 with a GF Score™ of 81/100 and a GF Value™ of ¥14.54 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 732 Biotechnology companies, Qingdao Vland Biotech Co ranks worse than 65.03% on this metric.
SHSE:603739's Gross Margin % is ranked worse than 65.03% of 732
companies
in the Biotechnology industry
Industry Median: 60.915
vs SHSE:603739: 44.75
Qingdao Vland Biotech Co had a gross margin of 44.23% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Qingdao Vland Biotech Co was -1.20% per year.
Qingdao Vland Biotech Co (SHSE:603739) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Qingdao Vland Biotech Co had a gross margin of 44.23% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Qingdao Vland Biotech Co Gross Margin % Related Terms
Qingdao Vland Biotech Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603739 vs VRTX, REGN, RVMD: Gross Margin % Comparison
For the Biotechnology subindustry, Qingdao Vland Biotech Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qingdao Vland Biotech Co Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Qingdao Vland Biotech Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Qingdao Vland Biotech Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Qingdao Vland Biotech Co (SHSE:603739) has a Gross Margin % of 44.23% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Qingdao Vland Biotech Co and its competitors. This is near median its historical median of 47.32. Over the past decade, Qingdao Vland Biotech Co's Gross Margin % has ranged from 43.23 to 54.69. According to the industry distribution chart, Qingdao Vland Biotech Co ranks #476 out of 732 companies in the Biotechnology industry, placing it in the top 65%.
Is Qingdao Vland Biotech Co's Gross Margin % too high?
Qingdao Vland Biotech Co's current Gross Margin % of 44.23% is near median its 10-year median of 47.32. Over the past 10 years, this metric has ranged from a low of 43.23 to a high of 54.69. The Biotechnology industry median Gross Margin % is 60.92. Qingdao Vland Biotech Co's value of 44.23% is 27.4% below this industry median. Based on the distribution chart, Qingdao Vland Biotech Co ranks #476 out of 732 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Qingdao Vland Biotech Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qingdao Vland Biotech Co's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Qingdao Vland Biotech Co ranks #476 out of 732 companies for Gross Margin %. This places Qingdao Vland Biotech Co in the lower half of its industry. The industry median Gross Margin % is 60.92. Qingdao Vland Biotech Co's value of 44.23% is 27.4% below this benchmark. Historically, Qingdao Vland Biotech Co's own Gross Margin % has ranged from 43.23 to 54.69 over the past decade. While the company's 10-year median is 47.32 vs. the industry median of 60.92, Qingdao Vland Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.92, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qingdao Vland Biotech Co's current Gross Margin % of 44.23% is 27.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Qingdao Vland Biotech Co and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qingdao Vland Biotech Co's current Gross Margin % is 44.23%, which is near median its own 10-year median of 47.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qingdao Vland Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Qingdao Vland Biotech Co (SHSE:603739) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.54, compared to a current price of ¥11.19 — trading 23% below its estimated fair value. The current Gross Margin % is 44.23%, which is near median its 10-year median of 47.32 and 27.4% below the Biotechnology industry median of 60.92. Qingdao Vland Biotech Co's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Qingdao Vland Biotech Co (SHSE:603739), the current Gross Margin % is 44.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qingdao Vland Biotech Co (SHSE:603739) Overvalued in 2026?
Based on GuruFocus' analysis, Qingdao Vland Biotech Co stock appears to be undervalued.
The current stock price of ¥11.19 is trading 23% below its estimated GF Value™ of ¥14.54.
GuruFocus considers Qingdao Vland Biotech Co to be Modestly Undervalued.
Key valuation signals for SHSE:603739:
Gross Margin %: 44.23% (near median its 10-year median of 47.32)
GF Value™: ¥14.54 vs. price of ¥11.19 (23% below fair value)
Industry Position: 27.4% below the Biotechnology median (#476 of 732)
No single metric tells the full story. See the SHSE:603739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
81GF Score
Get the complete analysis for SHSE:603739
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603739 has been successfully added to your 
